Conceptio
›
acute-myeloid-leukemia
Topic
acute-myeloid-leukemia
Knowledge-graph topic
· documents ABOUT acute-myeloid-leukemia across the archive
438
Documents about acute-myeloid-leukemia
Documents about acute-myeloid-leukemia
Table 1_Functional-genomic prioritization identifies MED12 as a candidate RNAi vulnerability in acute myeloid leukemia: evaluation of a T22 peptide-functionalized LNP-siRNA formulation.xlsx
#1052877
Figshare
Table 3_Functional-genomic prioritization identifies MED12 as a candidate RNAi vulnerability in acute myeloid leukemia: evaluation of a T22 peptide-functionalized LNP-siRNA formulation.xlsx
#1052878
Figshare
Table 2_Functional-genomic prioritization identifies MED12 as a candidate RNAi vulnerability in acute myeloid leukemia: evaluation of a T22 peptide-functionalized LNP-siRNA formulation.xlsx
#1052879
Figshare
Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia
#366608
ClinicalTrials.gov
A DOMAIN FOCUSED SCREEN IDENTIFIES MEAF6 AS A VULNERABILITY IN ACUTE MYELOID LEUKEMIA
#389835
ScholarlyCommons at Penn
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
#442106
ClinicalTrials.gov
Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure
#829917
ClinicalTrials.gov
Expanded Access Program of Ponatinib
#875908
ClinicalTrials.gov
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
#896926
ClinicalTrials.gov
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
#136397
ClinicalTrials.gov
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
#885440
ClinicalTrials.gov
MargheRITA (Remote Intelligence for Therapeutic Adherence)
#886424
ClinicalTrials.gov
Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years
#870088
ClinicalTrials.gov
MS-275 in Treating Patients With Hematologic Cancer
#849973
ClinicalTrials.gov
Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.
#864659
ClinicalTrials.gov
Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)
#879280
ClinicalTrials.gov
The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT
#982691
ClinicalTrials.gov
Supplementary file 1_Functional-genomic prioritization identifies MED12 as a candidate RNAi vulnerability in acute myeloid leukemia: evaluation of a T22 peptide-functionalized LNP-siRNA formulation.docx
#1052876
Figshare
Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML)
#883041
ClinicalTrials.gov
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
#843611
ClinicalTrials.gov
Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients
#840329
ClinicalTrials.gov
iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML
#891506
ClinicalTrials.gov
Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).
#1044278
ClinicalTrials.gov
Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.
#883578
ClinicalTrials.gov
Effect of Food on Blood Levels of ASTX727
#800919
ClinicalTrials.gov
Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML
#804747
ClinicalTrials.gov
Trial of Revumenib Plus FLA Chemotherapy for Children With Relapsed or Refractory NUP98-rearranged AML."
#853633
ClinicalTrials.gov
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
#854928
ClinicalTrials.gov
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
#867314
ClinicalTrials.gov
Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia
#15561
HAL (France)
Early Detection of Acute Myeloid Leukemia (AML) Using YOLOv12 Deep Learning Model
#31276
arXiv CS
Multiomic State-Transitions Reveal Post-Treatment Transcriptome Desynchronization in Acute Myeloid Leukemia
#300122
bioRxiv / medRxiv
Toward a unified classification of acute myeloid leukemia, myelodysplasia-related: a multicenter retrospective study
#373561
bioRxiv / medRxiv
Efficacy of G-CSF-Priming in Elderly AML Patients
#804565
ClinicalTrials.gov
High-dose Cytarabine and Survival in AML
#830461
ClinicalTrials.gov
CD123 Redirected Autologous T Cells for AML
#886216
ClinicalTrials.gov
Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)
#922994
HAL (France)
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
#895559
ClinicalTrials.gov
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
#831008
ClinicalTrials.gov
Preclinical advances and mechanistic insights of CAR-T therapy for acute myeloid leukemia: from target iteration to microenvironment regulation
#4573
Europe PMC
A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.
#842190
ClinicalTrials.gov
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
#901624
ClinicalTrials.gov
Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).
#863195
ClinicalTrials.gov
IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia
#268020
ClinicalTrials.gov
Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients
#873493
ClinicalTrials.gov
Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant
#283041
ClinicalTrials.gov
Identification of interconnected markers for T-cell acute lymphoblastic leukemia
#954518
Koc University Digital Collections
Evolving Management Approaches Toward Personalized Therapy in Acute Myeloid Leukemia: A Narrative Review.
#232323
NCBI PubMed Central
Global bibliometric analysis of TP53-mutated acute myeloid leukemia: research hotspots and evolution.
#368184
NCBI PubMed Central
Relationship Between Longitudinal Coping Strategies and Outcomes in Patients With Acute Myeloid Leukemia.
#382321
NCBI PubMed Central
← Previous
Page 13 of 19
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.